Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$28.65
+0.9%
$27.43
$23.69
$31.72
$12.54B0.68800,456 shs948,581 shs
STERIS plc stock logo
STE
STERIS
$243.21
-0.2%
$225.95
$200.98
$252.79
$23.90B0.96543,515 shs538,496 shs
Demant A/S stock logo
WILYY
Demant A/S
$20.20
$17.37
$15.03
$24.84
$8.64B0.98587 shsN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$92.85
+1.3%
$101.84
$89.92
$117.45
$18.37B0.781.79 million shs3.14 million shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Smith & Nephew plc stock logo
SNN
Smith & Nephew
+1.02%-0.63%+7.95%+9.67%+11.78%
STERIS plc stock logo
STE
STERIS
-0.16%-3.53%+8.42%+10.33%+5.47%
Demant A/S stock logo
WILYY
Demant A/S
0.00%+4.94%+34.43%+12.41%-14.77%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
+1.30%-4.07%-6.72%-11.48%-22.19%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Smith & Nephew plc stock logo
SNN
Smith & Nephew
2.1858 of 5 stars
1.03.02.50.03.10.03.1
STERIS plc stock logo
STE
STERIS
4.5625 of 5 stars
2.45.03.33.83.51.71.3
Demant A/S stock logo
WILYY
Demant A/S
N/AN/AN/AN/AN/AN/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
4.8573 of 5 stars
3.14.02.53.73.02.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Smith & Nephew plc stock logo
SNN
Smith & Nephew
2.00
Hold$28.00-2.27% Downside
STERIS plc stock logo
STE
STERIS
2.71
Moderate Buy$264.008.55% Upside
Demant A/S stock logo
WILYY
Demant A/S
3.33
BuyN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.29
Hold$111.5320.12% Upside

Current Analyst Ratings Breakdown

Latest WILYY, STE, ZBH, and SNN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
STERIS plc stock logo
STE
STERIS
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$240.00 ➝ $260.00
5/16/2025
STERIS plc stock logo
STE
STERIS
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/16/2025
STERIS plc stock logo
STE
STERIS
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$265.00 ➝ $280.00
5/15/2025
STERIS plc stock logo
STE
STERIS
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$250.00 ➝ $250.00
5/12/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$115.00 ➝ $101.00
5/7/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$140.00 ➝ $125.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$101.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$138.00 ➝ $115.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$120.00 ➝ $104.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$119.00 ➝ $104.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$125.00 ➝ $112.00
(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$5.81B2.16$3.58 per share8.00$11.94 per share2.40
STERIS plc stock logo
STE
STERIS
$5.46B4.38$15.46 per share15.73$65.43 per share3.72
Demant A/S stock logo
WILYY
Demant A/S
$3.25B2.66$1.07 per share18.94$3.16 per share6.39
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$7.70B2.39$11.83 per share7.85$62.67 per share1.48
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$263M$2.1613.2614.331.26N/AN/AN/A8/5/2025 (Estimated)
STERIS plc stock logo
STE
STERIS
$378.24M$6.2051.6424.49N/A8.66%13.91%8.64%8/5/2025 (Estimated)
Demant A/S stock logo
WILYY
Demant A/S
$346.38MN/A0.0017.72N/AN/AN/AN/A8/12/2025 (Estimated)
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$903.70M$4.5220.8610.471.9511.77%12.99%7.58%8/6/2025 (Estimated)

Latest WILYY, STE, ZBH, and SNN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q4 2025
STERIS plc stock logo
STE
STERIS
$2.59$2.74+$0.15$1.47$1.47 billion$1.48 billion
5/5/2025Q1 2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.77$1.81+$0.04$0.91$1.89 billion$1.91 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$0.893.11%N/A41.20%N/A
STERIS plc stock logo
STE
STERIS
$2.280.94%+9.51%36.77%20 Years
Demant A/S stock logo
WILYY
Demant A/S
N/AN/AN/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.961.03%N/A21.24%N/A

Latest WILYY, STE, ZBH, and SNN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2025
STERIS plc stock logo
STE
STERIS
quarterly$0.571.01%6/10/20256/10/20256/26/2025
2/26/2025
Smith & Nephew plc stock logo
SNN
Smith & Nephew
semi-annual$0.44702.5%3/28/20253/28/20255/28/2025
2/26/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.240.89%3/31/20253/31/20254/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Smith & Nephew plc stock logo
SNN
Smith & Nephew
0.63
2.51
1.11
STERIS plc stock logo
STE
STERIS
0.32
2.13
1.40
Demant A/S stock logo
WILYY
Demant A/S
1.29
1.63
1.06
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.43
1.91
0.99

Institutional Ownership

CompanyInstitutional Ownership
Smith & Nephew plc stock logo
SNN
Smith & Nephew
25.64%
STERIS plc stock logo
STE
STERIS
94.69%
Demant A/S stock logo
WILYY
Demant A/S
N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
Smith & Nephew plc stock logo
SNN
Smith & Nephew
1.00%
STERIS plc stock logo
STE
STERIS
1.14%
Demant A/S stock logo
WILYY
Demant A/S
N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
1.39%
CompanyEmployeesShares OutstandingFree FloatOptionable
Smith & Nephew plc stock logo
SNN
Smith & Nephew
20,100437.96 million432.83 millionOptionable
STERIS plc stock logo
STE
STERIS
16,00098.25 million97.13 millionOptionable
Demant A/S stock logo
WILYY
Demant A/S
21,623427.59 millionN/ANot Optionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
18,000197.85 million197.18 millionOptionable

Recent News About These Companies

Zimmer Biomet Marks Founders Day

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Smith & Nephew stock logo

Smith & Nephew NYSE:SNN

$28.65 +0.25 (+0.88%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$28.64 -0.01 (-0.05%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

STERIS stock logo

STERIS NYSE:STE

$243.21 -0.59 (-0.24%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$242.96 -0.24 (-0.10%)
As of 05/23/2025 04:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Demant A/S stock logo

Demant A/S OTCMKTS:WILYY

$20.20 0.00 (0.00%)
As of 05/23/2025

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$92.85 +1.18 (+1.28%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$92.66 -0.19 (-0.20%)
As of 05/23/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.